Ron Sabo

909 citations
22 papers · 740 indexed · h-index 13

Ron Sabo

21 papers receiving 688 citations

Peers

Ron Sabo
Comparison fields: 5 of 86
  • Endocrinology, Diabetes and Metabolism 352
  • Hepatology 159
  • Oncology 174
  • Epidemiology 197
  • Surgery 182
Replace Hans Ditschuneit with:
Hans Ditschuneit Germany
Yücel Batur Türkiye
Takefumi Kimura Japan
S. Galastri Italy
Irsan Hasan Indonesia
R Enat Israel
Seren Özeni̇rler Türkiye
Jianwei Zhang China
Yoichi Koizumi Japan
Hisham M. Nazer Saudi Arabia
Ron Sabo relative to Hans Ditschuneit Germany Hans Ditschuneit's profile →
Citations per field
00.5×7.8×
Hans Ditschuneit · 1×
Citations per year

Countries citing papers authored by Ron Sabo

Since Specialization
Citations

This map shows the geographic impact of Ron Sabo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Sabo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Sabo more than expected).

Fields of papers citing papers by Ron Sabo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Sabo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Sabo. The network helps show where Ron Sabo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ron Sabo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ron Sabo Line = papers co-authored together Ron Sabo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20113
2 20094
3 200756
4 200758
5 200738
6 200733
7 200764
8 200733
9 200738
10 200611
11 200613
12 20068
13 20036
14 20031
15 2000185
16 199915
17 1997104
18 19979
19 19961
20 198826

About Ron Sabo

Ron Sabo is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology, Family Practice, Hepatology and Pharmacy, having authored 22 papers that have together received 740 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (11 papers), Peptidase Inhibition and Analysis (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Pharmaceutical studies and practices (3 papers), Pharmacology and Obesity Treatment (2 papers), Immune Cell Function and Interaction (2 papers), Blood Pressure and Hypertension Studies (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (352 citations), Hepatology (159 citations), Oncology (174 citations), Epidemiology (197 citations) and Surgery (182 citations). Ron Sabo has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Monica Ligueros‐Saylan, Joelle Campestrini, William P. Dole, Dan Howard, Yanling He, Yibin Wang, Samir K. Gupta, Robert P. Clement, C Raffanel and Margaret Salfi. Their work appears in journals such as Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology, Current Medical Research and Opinion, Journal of Interferon & Cytokine Research and Journal of Allergy and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026